1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Radiopharmaceutical Theranostics Market – by Product Type

1.3.2        Europe Radiopharmaceutical Theranostics Market – by Radioisotope

1.3.3        Europe Radiopharmaceutical Theranostics Market – by Source

1.3.4        Europe Radiopharmaceutical Theranostics Market – by Application

1.3.5        Europe Radiopharmaceutical Theranostics Market – by Indication

1.3.6        Europe Radiopharmaceutical Theranostics Market – by End User

1.3.7        Europe Radiopharmaceutical Theranostics Market – by Country

2.           Radiopharmaceutical Theranostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Radiopharmaceutical Theranostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Expert’s Opinion

5.           Europe Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidence of Cancer

5.1.2        Rising Application in Treatment of Cardiovascular Disorders

5.2         Market Restraints

5.2.1        Regulatory Challenges for Approval of Radiopharmaceutical Theranostics

5.3         Market Opportunities

5.3.1        Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies

5.4         Future Trends

5.4.1        Radiopharmaceutical Theranostics in Nuclear Medicine

5.5         Impact Analysis

6.           Radiopharmaceutical Theranostics Market – Europe Analysis

6.1         Europe Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7.           Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

7.2.1        Positron Emission Tomography (PET) Tracers

7.2.1.1          Overview

7.2.1.2          Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2        Beta Emitters

7.2.2.1          Overview

7.2.2.2          Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.3        Alpha Emitters

7.2.3.1          Overview

7.2.3.2          Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1         Overview

8.2         Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)

8.2.1        Technetium-99

8.2.1.1          Overview

8.2.1.2          Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.2        Gallium-68

8.2.2.1          Overview

8.2.2.2          Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.3        Iodine-131

8.2.3.1          Overview

8.2.3.2          Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4        Iodine-123

8.2.4.1          Overview

8.2.4.2          Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.5        Fluorine-18 (18F)

8.2.5.1          Overview

8.2.5.2          Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.6        Yttrium 90 (Y-90)

8.2.6.1          Overview

8.2.6.2          Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.7        Lutetium (LU) 177

8.2.7.1          Overview

8.2.7.2          Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.8        Copper (CU) 67

8.2.8.1          Overview

8.2.8.2          Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.9        Copper (CU) 64

8.2.9.1          Overview

8.2.9.2          Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.10     Others

8.2.10.1       Overview

8.2.10.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Radiopharmaceutical Theranostics Market Analysis – by Source

9.1         Overview

9.2         Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)

9.2.1        Nuclear Reactors

9.2.1.1          Overview

9.2.1.2          Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.2        Cyclotrons

9.2.2.1          Overview

9.2.2.2          Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Radiopharmaceutical Theranostics Market Analysis – by Application

10.1      Overview

10.2      Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)

10.2.1     Targeted Therapeutic (Rx)

10.2.1.1       Overview

10.2.1.2       Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2     Companion Diagnostic (CDx)

10.2.2.1       Overview

10.2.2.2       Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        Europe Radiopharmaceutical Theranostics Market Analysis – by Indication

11.1      Overview

11.2      Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)

11.2.1     Oncology

11.2.1.1       Overview

11.2.1.2       Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.2     Neurology

11.2.2.1       Overview

11.2.2.2       Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3     Cardiology

11.2.3.1       Overview

11.2.3.2       Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.4     Others

11.2.4.1       Overview

11.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.        Europe Radiopharmaceutical Theranostics Market Analysis – by End User

12.1      Overview

12.2      Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)

12.2.1     Hospitals

12.2.1.1       Overview

12.2.1.2       Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.2     Diagnostic Imaging Centers

12.2.2.1       Overview

12.2.2.2       Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3     Academic & Research Institutes

12.2.3.1       Overview

12.2.3.2       Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.4     Others

12.2.4.1       Overview

12.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.        Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis

13.1      Europe: Radiopharmaceutical Theranostics Market

13.1.1     Overview

13.1.2     Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

13.1.2.1       Germany: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1       Overview

13.1.2.1.2       Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3       Germany Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.1.4       Germany Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.1.5       Germany Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.1.6       Germany Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.1.7       Germany Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.1.8       Germany Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.2       United Kingdom: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1       Overview

13.1.2.2.2       United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3       United Kingdom Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)

13.1.2.2.4       United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.2.5       United Kingdom Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.2.6       United Kingdom Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.2.7       United Kingdom Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.2.8       United Kingdom Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.3       France: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1       Overview

13.1.2.3.2       France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3       France Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.3.4       France Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.3.5       France Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.3.6       France Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.3.7       France Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.3.8       France Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.4       Italy: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.1       Overview

13.1.2.4.2       Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.3       Italy Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.4.4       Italy Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.4.5       Italy Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.4.6       Italy Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.4.7       Italy Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.4.8       Italy Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.5       Spain: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.1       Overview

13.1.2.5.2       Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.3       Spain Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.5.4       Spain Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.5.5       Spain Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.5.6       Spain Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.5.7       Spain Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.5.8       Spain Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.6       Rest of Europe: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.1       Overview

13.1.2.6.2       Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.3       Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.6.4       Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.6.5       Rest of Europe Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.6.6       Rest of Europe Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.6.7       Rest of Europe Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.6.8       Rest of Europe Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

14.        Radiopharmaceutical Theranostics Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Radiopharmaceutical Theranostics Market

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        Company Profiles

15.1      Bayer AG

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      GE HealthCare Technologies Inc

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Curium

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Lantheus Medical Imaging, Inc.

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      Telix Pharmaceuticals Ltd.

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Cardinal Health Inc

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Advanced Accelerator Applications S.A.

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      Theragnostics

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Germany Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             United Kingdom Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 9.             United Kingdom Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 10.          United Kingdom Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          United Kingdom Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12.          United Kingdom Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          France Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 15.          France Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 16.          France Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17.          France Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 18.          France Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Italy Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Italy Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Spain Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Spain Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Spain Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Spain Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Spain Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Spain Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Europe Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Europe Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Europe Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of Europe Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 38.          Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 39.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Radiopharmaceutical Theranostics Market Segmentation

Figure 2.           Europe Radiopharmaceutical Theranostics Market, by Country

Figure 3.           Europe Radiopharmaceutical Theranostics Market Overview

Figure 4.           Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market

Figure 5.           Germany Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Experts’ Opinion

Figure 8.           Europe Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        Europe Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Positron Emission Tomography (PET) Tracers: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028  (US$ Million)

Figure 12.        Beta Emitters: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Alpha Emitters: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)

Figure 15.        Technetium-99: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Gallium-68: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Iodine-131: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Iodine-123: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Fluorine-18 (18F): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Yttrium 90 (Y-90): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lutetium (LU) 177: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Copper (CU) 67: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Copper (CU) 64: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)

Figure 26.        Nuclear Reactors: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cyclotrons: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)

Figure 29.        Targeted Therapeutics (Rx): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Companion Diagnostics (CDx): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Europe Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)

Figure 32.        Oncology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Neurology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cardiology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Europe Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)

Figure 37.        Hospitals: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Diagnostic Imaging Centers: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Academic & Research Institutes: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Europe: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 42.        Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

Figure 43.        Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.        Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48.        Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49.        Growth Strategies in the Radiopharmaceutical Theranostics Market